Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

10,11 In particular, rapid and portable cancer ... screening for multiple diseases or genetic markers, also offers comprehensive diagnostic capabilities. 16 In the future, CRISPR diagnostics ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Learn more about whether Legend Biotech Corporation or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A first patient has been treated in a trial of an Allergan and Editas drug based on CRISPR/Cas9, a technology that allows genes to be manipulated ... therapy for lung cancer, and other studies ...

Learn more about whether Twist Bioscience Corporation or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.